Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Xencor IncXNCR · Entity 4487 | Chief Medical Officer | February 12, 2019 | February 14, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Xencor Inc
Report date February 12, 2019 · Filed February 14, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.31 · Expires 2029-02-11 | Direct | 50,420 |
Reported balance
After 2019-02-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-02-12 · Grant · Acquired 50,420 · Balance 50,420 F1: 25% of the shares subject to the option shall vest on the one year anniversary of February 12, 2019 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of the shares subject to the option shall vest on the one year anniversary of February 12, 2019 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2019 Filed Feb 14, 2019 21:41 UTC | Xencor Inc XNCR · Entity 4487 | GrantStock Option (right to buy) · Derivative | 50,420 | $0.00 Strike: $36.31 | $0.00 |
DisclosureSEC source: 0001209191-19-010217 · doc4.xml · derivative · entry 1 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,420 Underlying: Common Stock · 50,420 shares Expires 2029-02-11 F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on the one year anniversary of February 12, 2019 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:28 UTC | Xencor Inc XNCR · Entity 4487 | Exercise / conversionStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $11.05 | $0.00 |
DisclosureSEC source: 0001209191-18-051472 · doc4.xml · derivative · entry 3 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 40,000 shares Expires 2024-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:28 UTC | Xencor Inc XNCR · Entity 4487 | SaleCommon Stock | 40,000 | $46.03 | $1,841,208.00 |
DisclosureSEC source: 0001209191-18-051472 · doc4.xml · nonDerivative · entry 2 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,952 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted August 17, 2018. F2 · price: The weighted average sale price for the transaction reported was $46.0302, and the range of prices were between $46.0121 and $46.0782. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:28 UTC | Xencor Inc XNCR · Entity 4487 | Exercise / conversionCommon Stock | 40,000 | $11.05 | $442,000.00 |
DisclosureSEC source: 0001209191-18-051472 · doc4.xml · nonDerivative · entry 1 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted August 17, 2018. Read SEC document |
| August 17, 2018 Filed Aug 17, 2018 22:20 UTC | Xencor Inc XNCR · Entity 4487 | Exercise / conversionStock Option (right to buy) · Derivative | 3,659 | $0.00 Strike: $11.05 | $0.00 |
DisclosureSEC source: 0001209191-18-047522 · doc4.xml · derivative · entry 3 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 3,659 shares Expires 2024-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| August 17, 2018 Filed Aug 17, 2018 22:20 UTC | Xencor Inc XNCR · Entity 4487 | SaleCommon Stock | 3,659 | $40.10 | $146,725.90 |
DisclosureSEC source: 0001209191-18-047522 · doc4.xml · nonDerivative · entry 2 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,952 Read SEC document |
| August 17, 2018 Filed Aug 17, 2018 22:20 UTC | Xencor Inc XNCR · Entity 4487 | Exercise / conversionCommon Stock | 3,659 | $11.05 | $40,431.95 |
DisclosureSEC source: 0001209191-18-047522 · doc4.xml · nonDerivative · entry 1 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2018 Filed Aug 16, 2018 23:31 UTC | Xencor Inc XNCR · Entity 4487 | Exercise / conversionStock Option (right to buy) · Derivative | 20,739 | $0.00 Strike: $11.05 | $0.00 |
DisclosureSEC source: 0001209191-18-047214 · doc4.xml · derivative · entry 9 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,659 Underlying: Common Stock · 20,739 shares Expires 2024-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| August 16, 2018 Filed Aug 16, 2018 23:31 UTC | Xencor Inc XNCR · Entity 4487 | SaleCommon Stock | 20,739 | $41.10 | $852,372.90 |
DisclosureSEC source: 0001209191-18-047214 · doc4.xml · nonDerivative · entry 6 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,952 Read SEC document |
| August 16, 2018 Filed Aug 16, 2018 23:31 UTC | Xencor Inc XNCR · Entity 4487 | Exercise / conversionCommon Stock | 20,739 | $11.05 | $229,165.95 |
DisclosureSEC source: 0001209191-18-047214 · doc4.xml · nonDerivative · entry 5 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 23:31 UTC | Xencor Inc XNCR · Entity 4487 | Exercise / conversionStock Option (right to buy) · Derivative | 106 | $0.00 Strike: $11.05 | $0.00 |
DisclosureSEC source: 0001209191-18-047214 · doc4.xml · derivative · entry 8 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,398 Underlying: Common Stock · 106 shares Expires 2024-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 23:31 UTC | Xencor Inc XNCR · Entity 4487 | SaleCommon Stock | 106 | $41.10 | $4,356.60 |
DisclosureSEC source: 0001209191-18-047214 · doc4.xml · nonDerivative · entry 4 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,952 Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 23:31 UTC | Xencor Inc XNCR · Entity 4487 | Exercise / conversionCommon Stock | 106 | $11.05 | $1,171.30 |
DisclosureSEC source: 0001209191-18-047214 · doc4.xml · nonDerivative · entry 3 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 23:31 UTC | Xencor Inc XNCR · Entity 4487 | Exercise / conversionStock Option (right to buy) · Derivative | 15,496 | $0.00 Strike: $11.05 | $0.00 |
DisclosureSEC source: 0001209191-18-047214 · doc4.xml · derivative · entry 7 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,504 Underlying: Common Stock · 15,496 shares Expires 2024-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 23:31 UTC | Xencor Inc XNCR · Entity 4487 | SaleCommon Stock | 15,496 | $41.11 | $636,980.13 |
DisclosureSEC source: 0001209191-18-047214 · doc4.xml · nonDerivative · entry 2 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,952 F2 · price: The weighted average sale price for the transaction reported was $41.1061, and the range of prices were between $41.10 and $41.120. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 23:31 UTC | Xencor Inc XNCR · Entity 4487 | Exercise / conversionCommon Stock | 15,496 | $11.05 | $171,230.80 |
DisclosureSEC source: 0001209191-18-047214 · doc4.xml · nonDerivative · entry 1 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes the following shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan: 1,207 shares of Common Stock acquired on June 10, 2015, 1,212 shares of Common Stock acquired on December 10, 2015 and 114 shares of Common Stock acquired on June 9, 2018. Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 01:47 UTC | Xencor Inc XNCR · Entity 4487 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001209191-18-012777 · doc4.xml · derivative · entry 3 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,064 Underlying: Common Stock · 10,000 shares Expires 2022-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 01:47 UTC | Xencor Inc XNCR · Entity 4487 | SaleCommon Stock | 10,000 | $26.03 | $260,300.00 |
DisclosureSEC source: 0001209191-18-012777 · doc4.xml · nonDerivative · entry 2 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,419 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted November 23, 2015. Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 01:47 UTC | Xencor Inc XNCR · Entity 4487 | Exercise / conversionCommon Stock | 10,000 | $0.59 | $5,900.00 |
DisclosureSEC source: 0001209191-18-012777 · doc4.xml · nonDerivative · entry 1 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2018 Filed Feb 16, 2018 23:25 UTC | Xencor Inc XNCR · Entity 4487 | Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001209191-18-011018 · doc4.xml · derivative · entry 3 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,064 Underlying: Common Stock · 5,000 shares Expires 2022-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| February 16, 2018 Filed Feb 16, 2018 23:25 UTC | Xencor Inc XNCR · Entity 4487 | SaleCommon Stock | 5,000 | $25.01 | $125,050.00 |
DisclosureSEC source: 0001209191-18-011018 · doc4.xml · nonDerivative · entry 2 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,419 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted November 23, 2015. Read SEC document |
| February 16, 2018 Filed Feb 16, 2018 23:25 UTC | Xencor Inc XNCR · Entity 4487 | Exercise / conversionCommon Stock | 5,000 | $0.59 | $2,950.00 |
DisclosureSEC source: 0001209191-18-011018 · doc4.xml · nonDerivative · entry 1 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2018 Filed Jan 27, 2018 00:27 UTC | Xencor Inc XNCR · Entity 4487 | GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $23.40 | $0.00 |
DisclosureSEC source: 0001209191-18-005735 · doc4.xml · derivative · entry 1 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2028-01-23 F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on the one year anniversary of January 24, 2018 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date. Read SEC document |
| January 30, 2017 Filed Feb 2, 2017 02:02 UTC | Xencor Inc XNCR · Entity 4487 | GrantStock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $22.55 | $0.00 |
DisclosureSEC source: 0001209191-17-006895 · doc4.xml · derivative · entry 1 Foster Paul A · CIK 0001591213 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2027-01-29 F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on the one year anniversary of January 30, 2017 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.